Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Ralimetinib
Trade Name
Synonyms LY2228820|LY-2228820|LY 2228820
Drug Descriptions

Ralimetinib (LY2228820) is a selective ATP competitive inhibitor of p38 MAPK alpha (MAPK14) and beta (MAPK11), which inhibits tumor growth (PMID: 26581242, PMID: 24356814, PMID: 31791552, PMID: 31707688).

DrugClasses p38-alpha Inhibitor 1
CAS Registry Number 862505-00-8
NCIT ID C143046


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Gemcitabine + Ralimetinib Carboplatin Gemcitabine Ralimetinib 0 0
Prexasertib + Ralimetinib Prexasertib Ralimetinib 0 1
Ralimetinib Ralimetinib 0 1
Ralimetinib + SCH772984 Ralimetinib SCH772984 0 0

Additional content available in CKB BOOST